Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. J of Skin [Internet]. 2021 Jan. 1 [cited 2025 Apr. 19];5(1):s5. Available from: https://skin.dermsquared.com/skin/article/view/1157